Agios Pharmaceuticals, Inc. (AGIO)
NMS – Real Time Price. Currency in USD
34.05
+1.36 (4.16%)
Market open: Aug 12, 2026, 1:40 PM EDT
32.69
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
34.05
+1.36 (4.16%)
Market open: Aug 12, 2026, 1:40 PM EDT
32.69
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $99.6M significantly exceed its total debt $31.2M, ensuring strong financial flexibility
Total current assets $717.7M exceed Total current liabilities $70.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$58.5M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 10.22 | 6.05 | 10 | |
| Quick ratio | 9.79 | 5.63 | 10 | |
| Debt to Equity | 0.03 | 0.30 | 9.0 | |
| Debt to Assets | 0.03 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 14M | 27M | 36M | 54M | 98M |
| Gross Profit | -6M | 17M | 27M | 43M | 85M |
| Operating Income | -389M | -391M | -426M | -472M | -459M |
| Net Income | -232M | -352M | 674M | -413M | -411M |
| EBITDA | -370M | -385M | -420M | -467M | -454M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 317.09 | 31.77 | 10 |
| Next quarter | 216.39 | 41.76 | 10 |
| Current year | 237.8 | 20.22 | 10 |
| Next year | 86.21 | 32.02 | 10 |
| Weighted average score | 10 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 115.68 | -1.6 | 0 | 51.1 | 5.5 |
| Y/Y | 259.25 | 10.1 | 12.44 | 24.97 | 8.5 |
| 3y average | 57.49 | 26.07 | 24.36 | -7.54 | 7.8 |
| 5y average | 434.09 | 20.1 | 123.46 | -6.84 | 7.8 |
| Weighted average score | 7.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |